Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
J Physiol Pharmacol ; 72(2)2021 Apr.
Article in English | MEDLINE | ID: mdl-34374655

ABSTRACT

Previously, we have reported that ginsenoside Rg3 has typical activities for neuroprotection and Aß42 clearance by modulating microglia. In this study, we determined the pivotal role of ginsenoside Rg3 in microglia and neuronal cells. In human microglia, Rg3 and its stereoisomers significantly restored inflammatory M1 to normal M0 state and promoted M2 activation by up-regulating acute cytokines such as interleukin-10 and Arginase 1. Moreover, scavenger receptor type A (SRA) was significantly elevated in the presence of ginsenoside Rg3 and 20(S)-Rg3. This indicated that ginsenoside Rg3 could play a crucial role in Aß uptake and clearance under activated M2 state. We also observed that soluble amyloid precursor protein-alpha (sAPPα) and ADAM10 levels were increased in APP swe-transfected Nuro-2a neuronal cells, whereas sAPPß was not processed, suggesting that ginsenoside Rg3 was involved in non-amyloidogenic processing. In immunocytochemistry, SRA and a disintegrin and metalloproteinase 10 (desintegrin and metalloproteinase-containing protein 10, ADAM10) were coincidently upregulated in the presence of ginsenoside Rg3 and its stereoisomers compared to those in normal control. Taken together, these results suggested that ginsenoside Rg3 could boost acute activation of microglia, promote Aß uptake, and elevate the sAPPα processing under activated M2 state. Although in vivo studies need to be performed, it is certain that ginsenoside Rg3 is highly involved in ameliorating the pathogenesis of neurodegeneration and can be a promising candidate for treating Alzheimer's disease as a new therapeutic intervention.


Subject(s)
Alzheimer Disease , Ginsenosides , Alzheimer Disease/drug therapy , Cytokines , Ginsenosides/pharmacology , Humans , Microglia
2.
Asian-Australas J Anim Sci ; 27(1): 83-92, 2014 Jan.
Article in English | MEDLINE | ID: mdl-25049930

ABSTRACT

This experiment was conducted to evaluate the effects of dietary CP levels in gestation under equal lysine content on reproductive performance, blood metabolites and milk composition of gilts. A total of 25 gilts (F1, Yorkshire×Landrace) were allotted to 4 dietary treatments at breeding in a completely randomized design, and fed 1 of 4 experimental diets containing different CP levels (11%, 13%, 15%, or 17%) at 2.0 kg/d throughout the gestation. Body weight of gilts at 24 h postpartum tended to increase linearly (p = 0.09) as dietary CP level increased. In lactation, backfat thickness, ADFI, litter size and weaning to estrus interval (WEI) did not differ among dietary treatments. There were linear increases in litter and piglet weight at 21 d of lactation (p<0.05) and weight gain of litter (p<0.01) and piglet (p<0.05) throughout the lactation as dietary CP level increased. Plasma urea nitrogen levels of gilts in gestation and at 24 h postpartum were linearly elevated as dietary CP level increased (p<0.05). Free fatty acid (FFA) levels in plasma of gestating gilts increased as dietary CP level increased up to 15%, and then decreased with quadratic effects (15 d, p<0.01; 90 d, p<0.05), and a quadratic trend (70 d, p = 0.06). There were no differences in plasma FFA, glucose levels and milk composition in lactation. These results indicate that increasing dietary CP level under equal lysine content in gestation increases BW of gilts and litter performance but does not affect litter size and milk composition. Feeding over 13% CP diet for gestating gilts could be recommended to improve litter growth.

3.
Plant Cell ; 13(8): 1779-90, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11487692

ABSTRACT

Senescence is a sequence of biochemical and physiological events that constitute the final stage of development. The identification of genes that alter senescence has practical value and is helpful in revealing pathways that influence senescence. However, the genetic mechanisms of senescence are largely unknown. The leaf of the oresara9 (ore9) mutant of Arabidopsis exhibits increased longevity during age-dependent natural senescence by delaying the onset of various senescence symptoms. It also displays delayed senescence symptoms during hormone-modulated senescence. Map-based cloning of ORE9 identified a 693-amino acid polypeptide containing an F-box motif and 18 leucine-rich repeats. The F-box motif of ORE9 interacts with ASK1 (Arabidopsis Skp1-like 1), a component of the plant SCF complex. These results suggest that ORE9 functions to limit leaf longevity by removing, through ubiquitin-dependent proteolysis, target proteins that are required to delay the leaf senescence program in Arabidopsis.


Subject(s)
Arabidopsis Proteins , Arabidopsis/physiology , Carrier Proteins/physiology , Plant Leaves/physiology , Abscisic Acid/metabolism , Acetates/metabolism , Amino Acid Sequence , Arabidopsis/genetics , Base Sequence , Carrier Proteins/chemistry , Carrier Proteins/metabolism , Cyclopentanes/metabolism , DNA Primers , Ethylenes/metabolism , Genes, Plant , Molecular Sequence Data , Mutation , Oxylipins , Plant Proteins/metabolism , Sequence Homology, Amino Acid
4.
Nucleic Acids Res ; 29(24): 5009-16, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11812831

ABSTRACT

Translational initiation of the human BiP mRNA is directed by an internal ribosomal entry site (IRES) located in the 5'-untranslated region (5'-UTR). In order to understand the mechanism of the IRES-dependent translation of BiP mRNA, cellular proteins interacting with the BiP IRES were investigated. La autoantigen, which augments the translation of polioviral mRNA and hepatitis C viral mRNA, bound specifically to the second half of the 5'-UTR of the BiP IRES and enhanced translation of BiP mRNA in both in vitro and in vivo assays. This finding suggests that cellular and viral IRESs containing very different RNA sequences may share a common mechanism of translation.


Subject(s)
Autoantigens/metabolism , Carrier Proteins/genetics , Heat-Shock Proteins , Molecular Chaperones/genetics , Protein Biosynthesis/genetics , RNA, Messenger/genetics , Ribonucleoproteins/metabolism , 5' Untranslated Regions/genetics , Animals , Autoantigens/genetics , Binding Sites/genetics , COS Cells , Endoplasmic Reticulum Chaperone BiP , Gene Expression Regulation , Green Fluorescent Proteins , HeLa Cells , Humans , Luciferases/genetics , Luciferases/metabolism , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Protein Binding , RNA/genetics , RNA/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Ribonucleoproteins/genetics , SS-B Antigen
5.
J Mol Biol ; 304(2): 119-33, 2000 Nov 24.
Article in English | MEDLINE | ID: mdl-11080450

ABSTRACT

Translation initiation of human Bip mRNA is directed by an internal ribosomal entry site (IRES) located in the 5' non-translated region. No trans-acting factor possibly involved in this process has as of yet been identified. For the encephalomyocarditis virus and other picornaviruses, polypyrimidine tract-binding protein (PTB) has been found to enhance the translation through IRES elements, probably by interaction with the IRES structure. Here, we report that PTB specifically binds to the central region (nt 50-117) of the Bip 5' non-translated region. Addition of purified PTB to rabbit reticulocyte lysate and overexpression of PTB in Cos-7 cells selectively inhibited Bip IRES-dependent translation. On the other hand, depletion of endogenous PTB or addition of an RNA interacting with PTB enhanced the translational initiation directed by Bip IRES. These suggest that PTB can either enhance or inhibit IRES-dependent translation depending on mRNAs.


Subject(s)
5' Untranslated Regions/metabolism , Carrier Proteins/biosynthesis , Gene Expression Regulation , Heat-Shock Proteins , Molecular Chaperones/biosynthesis , Protein Biosynthesis , RNA-Binding Proteins/metabolism , Ribonucleoproteins/metabolism , 5' Untranslated Regions/genetics , Animals , Binding Sites , COS Cells , Carrier Proteins/genetics , Endoplasmic Reticulum Chaperone BiP , Gene Expression Regulation/drug effects , Genes, Reporter , Humans , Molecular Chaperones/genetics , Peptide Chain Initiation, Translational/drug effects , Polypyrimidine Tract-Binding Protein , Protein Binding , Protein Biosynthesis/drug effects , RNA-Binding Proteins/genetics , RNA-Binding Proteins/pharmacology , Rabbits , Regulatory Sequences, Nucleic Acid/genetics , Reticulocytes/metabolism , Ribonucleoproteins/genetics , Ribonucleoproteins/pharmacology , Ribosomes/drug effects , Ribosomes/metabolism , Sequence Deletion/genetics , Substrate Specificity , Transfection
6.
Protein Expr Purif ; 20(2): 196-206, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11049744

ABSTRACT

The nonstructural protein 3 (NS3) of the hepatitis C virus (HCV) is a bifunctional protein with protease and helicase activities. Nonstructural protein 4A (NS4A) is preceded by NS3 and augments the proteolytic activity of NS3 through protein-protein interaction. The central domain of NS4A has been shown to be sufficient for the enhancement of the NS3 protease activity. However, investigations on the roles of the N-terminal and the C-terminal regions of NS4A have been hampered by the difficulty of purification of full-length NS4A, a polypeptide that contains highly hydrophobic amino acid residues. Here we report a procedure by which one can produce and purify an active, full-length NS4A using maltose-binding protein fusion method. The full-length NS4A fused to the maltose binding protein is soluble and maintains its NS3 protease-enhancing activity.


Subject(s)
ATP-Binding Cassette Transporters , Coenzymes/isolation & purification , Coenzymes/metabolism , Escherichia coli Proteins , Hepacivirus/enzymology , Monosaccharide Transport Proteins , Viral Nonstructural Proteins/isolation & purification , Viral Nonstructural Proteins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Coenzymes/biosynthesis , Coenzymes/genetics , Electrophoresis, Polyacrylamide Gel , Endopeptidases/metabolism , Escherichia coli , Glycerol/pharmacology , Hepacivirus/genetics , Hydrogen-Ion Concentration , Kinetics , Maltose-Binding Proteins , Protein Binding/drug effects , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Sodium Chloride/pharmacology , Temperature , Viral Nonstructural Proteins/biosynthesis , Viral Nonstructural Proteins/genetics
7.
Anal Biochem ; 284(1): 42-8, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10933854

ABSTRACT

Hepatitis C virus (HCV) NS3 protease is responsible for the processing of the viral polyprotein and is considered as a primary target for the development of anti-HCV therapy. We have developed a genetic method in yeast to screen for good substrate sequences of the NS3 protease. A library of fusion proteins was constructed with a transcription factor, GAL4, linked to the intracellular domain of an integral membrane protein, STE2, by a randomized protease substrate sequence. In yeast cells expressing NS3 protease, the substrate sequences in the fusion proteins were specifically recognized and cleaved. This cleavage resulted in the release of GAL4 from the cytoplasmic membrane and the subsequent activation of reporter genes by GAL4, which was detected by the growth of yeast cells on selective media. Based on the analysis of 69 isolated substrate sequences, a consensus sequence was deduced: (Glu/Asp)-X-Val-Val-(Leu/Pro)-Cys / (Ser/Ala), with the scissile bond being located between Cys and Ser or Ala and X not being determined. This is largely consistent with the previous results obtained by biochemical methods. An oligopeptide containing the deduced sequence was highly efficiently cleaved in vitro by the purified NS3 protease. These data demonstrated that the present genetic method could be used as an efficient tool for the in vivo determination of substrate specificity of proteases.


Subject(s)
Saccharomyces cerevisiae Proteins , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/genetics , Amino Acids/chemistry , Chromatography, High Pressure Liquid , DNA-Binding Proteins , Fungal Proteins/metabolism , Gene Library , Genes, Reporter , Peptides/metabolism , Protein Structure, Tertiary , Receptors, Mating Factor , Receptors, Peptide/metabolism , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Substrate Specificity , Transcription Factors/metabolism
8.
J Virol ; 74(11): 5233-41, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10799599

ABSTRACT

It has been suggested that nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) plays a role in the incapacitation of interferon by inactivation of RNA-dependent protein kinase PKR. In order to further investigate the role of NS5A, we tried to identify cellular proteins interacting with NS5A by using the yeast two-hybrid system. The karyopherin beta3 gene was isolated from a human liver cell library as a protein interacting with NS5A. The protein-protein interaction between NS5A and karyopherin beta3 was confirmed by in vitro binding assay and an in vivo coimmunoprecipitation method. The effect of NS5A on the karyopherin beta3 activity was investigated using a yeast cell line containing mutations in both PSE1 and KAP123, genes that are homologous to the human karyopherin beta3 gene. Human karyopherin beta3 complemented the loss of the PSE1 and KAP123 functions, supporting growth of the double mutant cells. However, expression of NS5A hampered the growth of the double mutant cells supplemented with human karyopherin beta3. On the other hand, expression of NS5A by itself had no effect on the growth of the double mutant expressing wild-type yeast PSE1. This indicates that NS5A may inhibit karyopherin beta3 function via protein-protein interaction. The role of NS5A in HCV replication is discussed.


Subject(s)
Membrane Transport Proteins , Nuclear Proteins/metabolism , Saccharomyces cerevisiae Proteins , Viral Nonstructural Proteins/physiology , Animals , Binding Sites , COS Cells , Genetic Complementation Test , Hepacivirus , Humans , Nuclear Proteins/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Saccharomyces cerevisiae , Two-Hybrid System Techniques , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism , beta Karyopherins
9.
J Mol Biol ; 298(3): 395-405, 2000 May 05.
Article in English | MEDLINE | ID: mdl-10772858

ABSTRACT

Heterogeneous nuclear ribonucleoproteins (hnRNPs) are involved in several RNA-related biological processes such as transcription, pre-mRNA processing, mature mRNA transport to the cytoplasm, and translation. About 20 major hnRNPs from A1 to U are known. Among them, hnRNP A, D, E, I, and K are known to shuttle between the nucleus and the cytoplasm. hnRNP E2 has been seen to stabilize alpha-globin mRNA and to enhance polioviral mRNA translation. hnRNP K modulates transcription and translation of some mRNAs. hnRNP I and its homologue hnRNP L have been suggested to enhance translation of some IRES-dependent mRNAs. In order to better understand the molecular mechanisms of the biological functions of hnRNPs, we investigated protein-protein interactions of six hnRNPs (hnRNP A1, C1, E2, I, K, and L) using the yeast two-hybrid system and in vitro co-precipitation assays. All of the hnRNPs tested exerted homomeric interactions, and hnRNP E2, I, K, and L interacted with each other. In the case of hnRNP E2 and hnRNP K, the N-terminal half of the proteins containing two KH (K homologous) domains were required for protein-protein interaction, and the second quarter of hnRNP I and hnRNP L containing RRM2 (RNA recognition motif 2) was essential for protein-protein interaction. hnRNP A1 and C1 did not form complexes with other hnRNPs in our assay systems. This suggests that the hnRNPs could fall into two groups: one group, including hnRNP A1 and C1, involved in hnRNP core complex formation and another group, including hnRNP E2, I, K, and L, involved in a variety of RNA-related biological processes. Different combinations of the proteins of the second group may facilitate different biological processes in conjunction with other factors.


Subject(s)
Cell Nucleus/metabolism , Cytoplasm/metabolism , Heterogeneous-Nuclear Ribonucleoprotein Group A-B , Heterogeneous-Nuclear Ribonucleoprotein Group C , Ribonucleoproteins/metabolism , Amino Acid Motifs , Binding Sites , Biological Transport , Dimerization , Heterogeneous Nuclear Ribonucleoprotein A1 , Heterogeneous-Nuclear Ribonucleoprotein K , Heterogeneous-Nuclear Ribonucleoprotein L , Heterogeneous-Nuclear Ribonucleoproteins , Models, Biological , Precipitin Tests , Protein Binding , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Ribonucleoproteins/chemistry , Ribonucleoproteins/classification , Ribonucleoproteins/isolation & purification , Sequence Deletion/genetics , Substrate Specificity , Two-Hybrid System Techniques , Yeasts
10.
Plant Mol Biol ; 44(4): 513-27, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11197326

ABSTRACT

OsMADS1 is a MADS box gene controlling flower development in rice. In order to learn more about the function of OsMADS1, we searched for cellular proteins interacting with OsMADS1 employing the yeast two-hybrid system. Two novel proteins with MADS domains, which were named OsMADS14 and OsMADS15, were isolated from a rice cDNA library. OsMADS14 and -15 are highly homologous to the maize MADS box gene ZAP1 which is an orthologue of the floral homeotic gene APETALA1 (AP1). Interactions among the three MADS domain proteins were confirmed by in vitro experiments using GST-fused OsMADS1 expressed in Escherichia coli and in vitro translated proteins of OsMADS14 and -15. We determined which domains in OsMADS1, -14, and -15 were required for protein-protein interaction employing the two-hybrid system and pull-down experiments. While the K domain was essential for protein-protein interaction, a region preceded by the K domain augmented this interaction. Interestingly, the C-terminal region of OsMADS1 functioned as a transcriptional activation domain in yeast and mammalian cells, while, on the other hand, the C domains of OsMADS14 and -15 exhibited only very weak transcriptional activator functionality, if any at all.


Subject(s)
DNA, Plant/metabolism , DNA-Binding Proteins/metabolism , Genes, Plant/genetics , Oryza/genetics , Transcription Factors/metabolism , Amino Acid Sequence , Base Sequence , Binding Sites , DNA, Plant/genetics , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Genes, Plant/physiology , MADS Domain Proteins , Molecular Sequence Data , Plant Proteins , Protein Binding , Protein Structure, Tertiary , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid , Trans-Activators/genetics , Trans-Activators/physiology , Transcription Factors/chemistry , Transcription Factors/genetics , Transcriptional Activation , Two-Hybrid System Techniques
11.
Arch Virol ; 144(2): 329-43, 1999.
Article in English | MEDLINE | ID: mdl-10470257

ABSTRACT

We determined the subcellular localization of hepatitis C viral (HCV) proteins as a first step towards the understanding of the functions of these proteins in the mammalian cell (CHO-K1). We used fluorescence emitted from green fluorescent protein (GFP)-fused to the viral proteins to determine the subcellular localization of the viral proteins. We found that most of the viral proteins were excluded from the nucleus. Core exhibited a globular pattern near the nucleus. NS2 was concentrated in the perinuclear space. NS4A accumulated in the ER and the Golgi regions. NS3 was detected in the nucleus as well as the cytoplasm, when it was expressed by itself. However, NS3 became restricted to the cytoplasm, when it was produced together with NS4A. NS4B showed a spot-like pattern throughout the cytoplasm. NS5A and NS5B were distributed throughout the cytoplasm in a mesh-like pattern. These results can provide a basis for further investigations into the functions of the HCV proteins.


Subject(s)
Hepacivirus/metabolism , Viral Proteins/analysis , Animals , CHO Cells , COS Cells , Cell Nucleus/metabolism , Cricetinae , Cytoplasm/metabolism , Gene Expression , Green Fluorescent Proteins , Hepacivirus/genetics , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Microscopy, Fluorescence , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/genetics , Viral Nonstructural Proteins/analysis , Viral Nonstructural Proteins/genetics , Viral Proteins/genetics
12.
Plant Mol Biol ; 40(3): 419-29, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10437826

ABSTRACT

APETALA1 (AP1) of Arabidopsis thaliana is a transcription factor controlling flower development. AP2 is a member of the MADS (MCM1, AGAMOUS, DEFICIENS, SRF) superfamily, which plays important roles in differentiation in plants and animals. MADS domains, which function most importantly in DNA binding, are found in all major eukaryotic kingdoms. In plants, MADS domain-containing proteins also possess a region of moderate sequence similarity named the K domain, which is involved in protein-protein interaction. Little is known about the function of a third, highly variable, domain designated the C domain, as it resides at the C terminus of the MADS proteins of plants. Here we report that the C-terminal domain of Arabidopsis thaliana AP1 and its homologues perform a transcriptional activation function. The C-terminal region of AP1 is composed of at least two separable transcriptional activation domains that function synergistically.


Subject(s)
Arabidopsis/genetics , Homeodomain Proteins/genetics , Plant Proteins/genetics , Transcription Factors/genetics , Amino Acid Sequence , Animals , Arabidopsis/metabolism , Arabidopsis Proteins , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Genes, Homeobox , Genes, Plant , Homeodomain Proteins/chemistry , Homeodomain Proteins/metabolism , MADS Domain Proteins , Molecular Sequence Data , Plant Proteins/chemistry , Plant Proteins/metabolism , Plants/genetics , Sequence Homology, Amino Acid , Transcription Factors/chemistry , Transcription Factors/metabolism , Transcriptional Activation
13.
Biochim Biophys Acta ; 1436(3): 319-30, 1999 Jan 04.
Article in English | MEDLINE | ID: mdl-9989263

ABSTRACT

The subcellular location of phospholipase D1 (PLD1) and its activation by protein kinase C alpha (PKC alpha) were examined by subcellular fractionation and by microscopic observation of green fluorescent protein-fused PLD1 (GFP-PLD1) or PKC alpha (GFP-PKC alpha) in fibroblastic 3Y1 cells. Major PLD1 immunoreactivity and PKC alpha-stimulated PLD activity segregated with a plasma membrane marker, even though a significant amount was co-fractionated with markers for endoplasmic reticulum (ER) and Golgi. Upon treatment with phorbol myristate acetate (PMA), PKC alpha translocated from the cytosolic fraction to the membrane fraction to which PLD1 also localized. GFP-PLD1 was found in the plasma membrane as well as a in a perinuclear compartment consistent with ER and Golgi and in other dispersed vesicular structures in the cytoplasm. However, most of GFP-PKC alpha was translocated from the cytosol to the plasma membrane after treatment with PMA. From these results, we concluded that the plasma membrane is the major site of PLD1 activation by PKC alpha in 3Y1 cells.


Subject(s)
Cell Membrane/enzymology , Isoenzymes/metabolism , Phospholipase D/metabolism , Protein Kinase C/metabolism , Animals , Biological Transport, Active/drug effects , Cell Line , Endoplasmic Reticulum/enzymology , Enzyme Activation/drug effects , Gene Expression , Golgi Apparatus/enzymology , Green Fluorescent Proteins , Isoenzymes/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Fluorescence , Phospholipase D/genetics , Protein Kinase C/genetics , Protein Kinase C-alpha , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Subcellular Fractions/enzymology , Tetradecanoylphorbol Acetate/pharmacology
14.
J Virol ; 72(11): 8782-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9765422

ABSTRACT

Translation initiation of hepatitis C virus (HCV) RNA occurs by internal entry of a ribosome into the 5' nontranslated region in a cap-independent manner. The HCV RNA sequence from about nucleotide 40 up to the N terminus of the coding sequence of the core protein is required for efficient internal initiation of translation, though the precise border of the HCV internal ribosomal entry site (IRES) has yet to be determined. Several cellular proteins have been proposed to direct HCV IRES-dependent translation by binding to the HCV IRES. Here we report on a novel cellular protein that specifically interacts with the 3' border of the HCV IRES in the core-coding sequence. This protein with an apparent molecular mass of 68 kDa turned out to be heterogeneous nuclear ribonucleoprotein L (hnRNP L). The binding of hnRNP L to the HCV IRES correlates with the translational efficiencies of corresponding mRNAs. This finding suggests that hnRNP L may play an important role in the translation of HCV mRNA through the IRES element.


Subject(s)
Hepacivirus/genetics , Hepacivirus/metabolism , Ribonucleoproteins/metabolism , Ribosomes/metabolism , Ribosomes/virology , Base Sequence , Binding Sites , DNA Primers/genetics , HeLa Cells , Heterogeneous-Nuclear Ribonucleoprotein L , Heterogeneous-Nuclear Ribonucleoproteins , Humans , Molecular Weight , Protein Biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Viral/genetics , RNA, Viral/metabolism , Ribonucleoproteins/chemistry
15.
Acta Crystallogr D Biol Crystallogr ; 54(Pt 1): 121-3, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9761831

ABSTRACT

The NS3 protein of hepatitis C virus (HCV) is thought to be essential for viral replication. The N-terminal domain of the protein contains protease activity and the C-terminal domain contains nucleotide triphosphatase and RNA helicase activity. The RNA helicase domain of HCV NS3 protein was purified by using affinity-column chromatographic methods, and crystallized by using the microbatch crystallization method under oil at 277 K. The crystals belong to primitive trigonal space group P3121 or P3221 with cell dimensions of a = b = 93.3, c = 104.6 A. The asymmetric unit contains one molecule of the helicase domain, with the crystal volume per protein mass (Vm) of 2.50 A3 Da-1 and solvent content of about 50.8% by volume. A native data set to 2.3 A resolution was obtained from a frozen crystal indicating that the crystals are quite suitable for structure determination by multiple isomorphous replacement.


Subject(s)
RNA Helicases , Viral Nonstructural Proteins/chemistry , Amino Acid Sequence , Catalytic Domain , Crystallization , Crystallography, X-Ray , Molecular Sequence Data
16.
J Biol Chem ; 273(24): 15045-52, 1998 Jun 12.
Article in English | MEDLINE | ID: mdl-9614113

ABSTRACT

Crystal structure of RNA helicase domain from genotype 1b hepatitis C virus has been determined at 2.3 A resolution by the multiple isomorphous replacement method. The structure consists of three domains that form a Y-shaped molecule. One is a NTPase domain containing two highly conserved NTP binding motifs. Another is an RNA binding domain containing a conserved RNA binding motif. The third is a helical domain that contains no beta-strand. The RNA binding domain of the molecule is distinctively separated from the other two domains forming an interdomain cleft into which single stranded RNA can be modeled. A channel is found between a pair of symmetry-related molecules which exhibit the most extensive crystal packing interactions. A stretch of single stranded RNA can be modeled with electrostatic complementarity into the interdomain cleft and continuously through the channel. These observations suggest that some form of this dimer is likely to be the functional form that unwinds double stranded RNA processively by passing one strand of RNA through the channel and passing the other strand outside of the dimer. A "descending molecular see-saw" model is proposed that is consistent with directionality of unwinding and other physicochemical properties of RNA helicases.


Subject(s)
Viral Nonstructural Proteins/chemistry , Acid Anhydride Hydrolases/chemistry , Binding Sites , Crystallography, X-Ray , Dimerization , Genotype , Models, Molecular , Nucleic Acid Conformation , Nucleoside-Triphosphatase , Protein Folding , Protein Structure, Secondary , RNA, Double-Stranded/chemistry , RNA-Binding Proteins/chemistry
17.
Biochem J ; 331 ( Pt 1): 169-75, 1998 Apr 01.
Article in English | MEDLINE | ID: mdl-9512476

ABSTRACT

Polypyrimidine-tract-binding protein (PTB) is involved in pre-mRNA splicing and internal-ribosomal-entry-site-dependent translation. The biochemical properties of various segments of PTB were analysed in order to understand the molecular basis of the PTB functions. The protein exists in oligomeric as well as monomeric form. The central part of PTB (amino acids 169-293) plays a major role in the oligomerization. PTB contains several RNA-binding motifs. Among them, the C-terminal part of PTB (amino acids 329-530) exhibited the strongest RNA-binding activity. The N-terminal part of PTB is responsible for the enhancement of RNA binding by HeLa cell cytoplasmic factor(s).


Subject(s)
RNA-Binding Proteins/chemistry , RNA-Binding Proteins/metabolism , RNA/metabolism , Ribonucleoproteins/chemistry , Ribonucleoproteins/metabolism , Amino Acid Sequence , Binding Sites/genetics , Cross-Linking Reagents , HeLa Cells , Humans , Molecular Sequence Data , Mutation , Polypyrimidine Tract-Binding Protein , RNA-Binding Proteins/genetics , Ribonucleoproteins/genetics , Sequence Analysis , Structure-Activity Relationship
18.
FEBS Lett ; 425(3): 401-6, 1998 Apr 03.
Article in English | MEDLINE | ID: mdl-9563502

ABSTRACT

Polypyrimidine tract-binding protein (PTB) is involved in pre-mRNA splicing and internal ribosomal entry site (IRES)-dependent translation. In order to identify cellular protein(s) interacting with PTB, we performed a yeast two-hybrid screening. Heterogeneous nuclear ribonucleoprotein L (hnRNP L) was identified as a PTB-binding protein. The interaction between PTB and hnRNP L was confirmed in an in vitro binding assay. Both PTB and hnRNP L were found to localize in the nucleoplasm, excepting the nucleoli, in HeLa cells by the green fluorescent protein (GFP)-fused protein detection method. The N-terminal half of PTB (aa 1-329) and most of hnRNP L (aa 141-558) is required for the interaction between PTB and hnRNP L.


Subject(s)
DNA-Binding Proteins/metabolism , RNA-Binding Proteins/metabolism , Ribonucleoproteins/metabolism , Genes, Reporter/genetics , Green Fluorescent Proteins , HeLa Cells , Heterogeneous-Nuclear Ribonucleoprotein L , Heterogeneous-Nuclear Ribonucleoproteins , Humans , Luminescent Proteins/genetics , Microscopy, Fluorescence , Nuclear Proteins/metabolism , Polypyrimidine Tract-Binding Protein , Protein Biosynthesis/genetics , RNA Precursors/metabolism , RNA Splicing/physiology , Recombinant Fusion Proteins/metabolism , Sequence Deletion/genetics , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
19.
Mol Cells ; 7(5): 661-7, 1997 Oct 31.
Article in English | MEDLINE | ID: mdl-9387155

ABSTRACT

Hepatitis C virus (HCV), a major etiologic agent of transfusion associated hepatitis, is a positive, single-stranded RNA virus and is also known to be implicated in liver cirrhosis and hepatocellular carcinoma. Nonstructural protein 5A (NS5A) of HCV contains acidic and proline-rich amino acids in its carboxy-terminal half. These structural features resemble eukaryotic transcription activators. In this report, we show that NS5A functions as a potent transcriptional activator when fused to the yeast (Saccharomyces cerevisiae) GAL4 DNA-binding domain (1-147). The potential transcriptional activator maps to the C-terminal half of NS5A in the yeast cell. Therefore, our data provides the first evidence that NS5A may modulate host cell function at the transcriptional level.


Subject(s)
Hepacivirus/genetics , Trans-Activators/chemistry , Viral Nonstructural Proteins/genetics , Gene Expression Regulation, Viral , Genome, Viral , Hepacivirus/chemistry , Hepacivirus/physiology , Protein Structure, Tertiary , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/virology , Trans-Activators/genetics , Transformation, Genetic , Viral Nonstructural Proteins/chemistry
20.
Virology ; 226(2): 318-26, 1996 Dec 15.
Article in English | MEDLINE | ID: mdl-8955051

ABSTRACT

Hepatitis C virus (HCV) is the major etiologic agent of non-A, non-B hepatitis. One of the difficulties in developing anti-HCV drugs is the lack of an efficient HCV cultivation system. We have generated an artificial surrogate virus suitable for testing the antiviral effects of drugs affecting HCV protease NS3, an enzyme believed to be essential for HCV proliferation. The surrogate virus genome is composed of most of the poliovirus genome and HCV protease NS3 and an NS3-specific cleavage site. The activity of HCV protease NS3 is required for proliferation of this chimeric virus. The antiviral efficacy of HCV protease inhibitors can, therefore, be evaluated by examining the effects of the drugs on the surrogate virus proliferation.


Subject(s)
Antiviral Agents/pharmacology , Hepacivirus/enzymology , Poliovirus/genetics , Serine Endopeptidases/genetics , Viral Nonstructural Proteins/genetics , Amino Acid Sequence , HeLa Cells , Hepacivirus/drug effects , Hepacivirus/genetics , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , Open Reading Frames , Protein Processing, Post-Translational , Reassortant Viruses/drug effects , Reassortant Viruses/enzymology , Reassortant Viruses/genetics , Reassortant Viruses/growth & development , Serine Endopeptidases/metabolism , Serine Proteinase Inhibitors/pharmacology , Viral Nonstructural Proteins/antagonists & inhibitors , Viral Nonstructural Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...